The Role of Colchicine in Acute Coronary Syndromes
Authors:
- 1 January 2019
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 41 (1) , 11-20
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammationAtherosclerosis, 2018
- Will Reducing Inflammation Reduce Vascular Event Rates?JACC: Cardiovascular Imaging, 2018
- Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary SyndromeJACC: Cardiovascular Imaging, 2018
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseNew England Journal of Medicine, 2017
- A Prospective Natural-History Study of Coronary AtherosclerosisNew England Journal of Medicine, 2011
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- C-Reactive Protein Levels and Outcomes after Statin TherapyNew England Journal of Medicine, 2005
- La inflamación en los síndromes coronarios agudos: mecanismos e implicaciones clínicasRevista Espanola de Cardiologia, 2004
- Inflammation in acute coronary syndromesHeart, 2002